The DOI matches its Crossref record; 140 of the 140 references it cites were found in a registry or an index.
Role of RAGE in Alzheimer’s Disease
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. (1996) · Nature · doi:10.1038/382685a0 · Cited by 2,012 · cited 1×
“It is well identified that RAGE-ligands interaction triggers a series of cellular signaling transduction cascades resulting in chronic inflammation and cellular stress (Yan et al. 1996).”
BackgroundUnderstanding RAGE, the receptor for advanced glycation end products
Bierhaus, A., Humpert, P. M., Morcos, M., Wendt, T., Chavakis, T., Arnold, B., Stern, D. M., & Nawroth, P. P. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0688-7 · Cited by 1,297 · cited 4×
“Such ligands include AGEs, Ab in AD, high mobility group box-1 protein, (HMGB1, amphoterin), S100,Mac-1 and phosphatidylserine (Bierhaus et al. 2005; Opatrna et al. 2014).”
BackgroundInfluentialAdvanced glycation end products contribute to amyloidosis in Alzheimer disease
Vitek, M. P., Bhattacharya, K., Glendening, J. M., Stopa, E., Vlassara, H., Bucala, R., Manogue, K., & Cerami, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4766 · Cited by 806 · cited 16×
“Simultaneously, research literature has evidenced that increased cytoplasmic Ca 2? levels is a major activator of AMPK signaling, and misregulation of CaMKKb–AMPK signaling is linked to the pathogenesis of Alzheimer's disease, such as chronic neuroinflammation, oxidative stress, aberrant tau hyperphosphorylation, and…”
BackgroundInfluentialThe Primary Structure and Heterogeneity of Tau Protein from Mouse Brain
Lee, G., Cowan, N., & Kirschner, M. (1988) · Science · doi:10.1126/science.3122323 · Cited by 678
Chen, Z., & Zhong, C. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.06.004 · Cited by 673
Iba, M., Guo, J. L., McBride, J. D., Zhang, B., Trojanowski, J. Q., & Lee, V. M.-Y. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.2642-12.2013 · Cited by 664 · cited 1×
“Tau protein is a microtubule-associated protein mainly expressed in neurons and plays a crucial role in the neuronal cytoskeleton stabilization (Tabaton et al. 1989; Schmidt et al. 1996; Iba et al. 2013).”
BackgroundBrain fuel metabolism, aging, and Alzheimer’s disease
Cunnane, S., Nugent, S., Roy, M., Courchesne-Loyer, A., Croteau, E., Tremblay, S., Castellano, A., Pifferi, F., Bocti, C., Paquet, N., et al. (2011) · Nutrition · doi:10.1016/j.nut.2010.07.021 · Cited by 614
Kapogiannis, D., & Mattson, M. P. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70277-5 · Cited by 594
Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress.
Yan, S. D., Chen, X., Schmidt, A. M., Brett, J., Godman, G., Zou, Y. S., Scott, C. W., Caputo, C., Frappier, T., & Smith, M. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.16.7787 · Cited by 565
Alafuzoff, I., Arzberger, T., Al‐Sarraj, S., Bodi, I., Bogdanovic, N., Braak, H., Bugiani, O., Del‐Tredici, K., Ferrer, I., Gelpi, E., et al. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00147.x · Cited by 467 · cited 2×
“As one of the hallmarks of AD, the NFTs eventually occupy the whole of the cytoplasm in certain classes of cell in the neocortex, hippocampus , brain stem, and diencephalon (Alafuzoff et al. 2008; Perez et al. 2013).”
BackgroundBrain metabolic dysfunction at the core of Alzheimer's disease
de la Monte, S. M., & Tong, M. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.12.012 · Cited by 461
Tau, tangles, and Alzheimer's disease
Binder, L. I., Guillozet-Bongaarts, A. L., Garcia-Sierra, F., & Berry, R. W. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.08.014 · Cited by 434
Advanced Glycation End Products in Alzheimer's Disease and Other Neurodegenerative Diseases
Sasaki, N., Fukatsu, R., Tsuzuki, K., Hayashi, Y., Yoshida, T., Fujii, N., Koike, T., Wakayama, I., Yanagihara, R., Garruto, R., et al. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65659-3 · Cited by 408
Yan, S. D., Yan, S. F., Chen, X., Fu, J., Chen, M., Kuppusamy, P., Smith, M. A., Perry, G., Godman, G. C., Nawroth, P., et al. (1995) · Nature Medicine · doi:10.1038/nm0795-693 · Cited by 406
Kvartsberg, H., Duits, F. H., Ingelsson, M., Andreasen, N., Öhrfelt, A., Andersson, K., Brinkmalm, G., Lannfelt, L., Minthon, L., Hansson, O., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.10.009 · Cited by 340
Advanced glycation end products and neurodegenerative diseases: Mechanisms and perspective
Li, J., Liu, D., Sun, L., Lu, Y., & Zhang, Z. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.02.018 · Cited by 319
Synaptic changes in Alzheimer’s disease and its models
Pozueta, J., Lefort, R., & Shelanski, M. L. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2012.05.050 · Cited by 307
RAGE (receptor for advanced glycation end products): a central player in the inflammatory response
Chavakis, T., Bierhaus, A., & Nawroth, P. P. (2004) · Microbes and Infection · doi:10.1016/j.micinf.2004.08.004 · Cited by 301
Advanced glycation endproducts in ageing and Alzheimer's disease
Münch, G., Thome, J., Foley, P., Schinzel, R., & Riederer, P. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(96)00016-1 · Cited by 275
Faden, A. I., & Loane, D. J. (2015) · Neurotherapeutics · doi:10.1007/s13311-014-0319-5 · Cited by 245
Carnevale, D., Mascio, G., D'Andrea, I., Fardella, V., Bell, R. D., Branchi, I., Pallante, F., Zlokovic, B., Yan, S. S., & Lembo, G. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.195511 · Cited by 241
Receptor for Advanced Glycation End Products and Its Involvement in Inflammatory Diseases
Chuah, Y. K., Basir, R., Talib, H., Tie, T. H., & Nordin, N. (2013) · International Journal of Inflammation · doi:10.1155/2013/403460 · Cited by 240
AMP‐activated protein kinase: a potential player in Alzheimer’s disease
Salminen, A., Kaarniranta, K., Haapasalo, A., Soininen, H., & Hiltunen, M. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07331.x · Cited by 222
De Silva, R., Lashley, T., Gibb, G., Hanger, D., Hope, A., Reid, A., Bandopadhyay, R., Utton, M., Strand, C., Jowett, T., et al. (2003) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2003.00463.x · Cited by 220
Takeuchi, M., & Yamagishi, S.-I. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784139693 · Cited by 218
Advanced glycation end products, oxidant stress and vascular lesions
CHAPPEY, O., DOSQUET, C., WAUTIER, M., & WAUTIER, J. (1997) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1997.710624.x · Cited by 214
Valente, T., Gella, A., Fernàndez-Busquets, X., Unzeta, M., & Durany, N. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.09.008 · Cited by 209
Mechanisms of Amyloid-β Peptide Clearance: Potential Therapeutic Targets for Alzheimer's Disease
Yoon, S.-S., & AhnJo, S.-M. (2012) · Biomolecules and Therapeutics · doi:10.4062/biomolther.2012.20.3.245 · Cited by 205 · cited 1×
“RAGE: The Most Important Role in the Failure of Ab Clearance Increasing research studies on Ab clearance mechanism provide new insight into the pathogenesis of AD at the molecular level which implicates that AD may result from a failure of Ab clearance in brain (Yoon and Jo 2012).”
BackgroundAGEs induce Alzheimer-like tau pathology and memory deficit via RAGE-mediated GSK-3 activation
Li, X.-H., Lv, B.-L., Xie, J.-Z., Liu, J., Zhou, X.-W., & Wang, J.-Z. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.02.003 · Cited by 205
Molecular links between Alzheimer’s disease and diabetes mellitus
Yang, Y., & Song, W. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.07.009 · Cited by 201
Kenessey, A., Nacharaju, P., Ko, L., & Yen, S. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69052026.x · Cited by 188
Clinical trial of an inhibitor of RAGE-Aβ interactions in Alzheimer disease
Galasko, D., Bell, J., Mancuso, J. Y., Kupiec, J. W., Sabbagh, M. N., van Dyck, C., Thomas, R. G., Aisen, P. S., & Study, F. T. A. D. C. (2014) · Neurology · doi:10.1212/wnl.0000000000000364 · Cited by 187
Xue, J., Ray, R., Singer, D., Böhme, D., Burz, D. S., Rai, V., Hoffmann, R., & Shekhtman, A. (2014) · Biochemistry · doi:10.1021/bi500046t · Cited by 186
Luth, H.-J. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhh123 · Cited by 186
Glycation exacerbates the neuronal toxicity of β-amyloid
Li, X.-H., Du, L.-L., Cheng, X.-S., Jiang, X., Zhang, Y., Lv, B.-L., Liu, R., Wang, J.-Z., & Zhou, X.-W. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.180 · Cited by 177
Leuner, K., Müller, W. E., & Reichert, A. S. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8307-4 · Cited by 177
Hoyer, S. (2000) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00156-x · Cited by 174
Role of Neuroinflammation in Adult Neurogenesis and Alzheimer Disease: Therapeutic Approaches
Fuster-Matanzo, A., Llorens-Martín, M., Hernández, F., & Ávila, J. (2013) · Mediators of Inflammation · doi:10.1155/2013/260925 · Cited by 172
The sour side of neurodegenerative disorders: the effects of protein glycation
Miranda, H. V., & Outeiro, T. F. (2010) · The Journal of Pathology · doi:10.1002/path.2682 · Cited by 169
Wan, W., Cao, L., Liu, L., Zhang, C., Kalionis, B., Tai, X., Li, Y., & Xia, S. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13122 · Cited by 168
Salahuddin, P., Rabbani, G., & Khan, R. (2014) · Cellular and Molecular Biology Letters · doi:10.2478/s11658-014-0205-5 · Cited by 167
Purushothuman, S., Johnstone, D. M., Nandasena, C., Mitrofanis, J., & Stone, J. (2014) · Alzheimer's Research & Therapy · doi:10.1186/alzrt232 · Cited by 165
Tangen, G. G., Engedal, K., Bergland, A., Moger, T. A., & Mengshoel, A. M. (2014) · Physical Therapy · doi:10.2522/ptj.20130298 · Cited by 165
Advanced glycation end products and diabetic complications
Stitt, A. W., Jenkins, A. J., & Cooper, M. E. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.9.1205 · Cited by 162
Sabbagh, M. N., Agro, A., Bell, J., Aisen, P. S., Schweizer, E., & Galasko, D. (2011) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318204b550 · Cited by 160
Mitochondrial Alterations, Oxidative Stress and Neuroinflammation in Alzheimer's Disease
Verri, M., Pastoris, O., Dossena, M., Aquilani, R., Guerriero, F., Cuzzoni, G., Venturini, L., Ricevuti, G., & Bongiorno, A. I. (2012) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463201202500204 · Cited by 154
Aβ-induced formation of autophagosomes is mediated by RAGE-CaMKKβ-AMPK signaling
Son, S. M., Jung, E. S., Shin, H. J., Byun, J., & Mook‐Jung, I. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.09.039 · Cited by 151
Liu, R., Wu, C., Zhou, D., Yang, F., Tian, S., Zhang, L., Zhang, T., & Du, G. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-105 · Cited by 150
Yamagishi, S., Fukami, K., & Matsui, T. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0176-5 · Cited by 135
Zong, H., Madden, A. F., Ward, M. S., Mooney, M. H., Elliott, C. T., & Stitt, A. W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.133827 · Cited by 134
Soluble form of a receptor for advanced glycation end products sRAGE as a biomarker
Yamagishi, S., & Matsui, T. (2010) · Frontiers in Bioscience-Elite · doi:10.2741/e178 · Cited by 134
Involvement of Advanced Glycation End-products (AGEs) in Alzheimers Disease
Takeuchi, M., Kikuchi, S., Sasaki, N., Suzuki, T., 渡井孝幸, Iwaki, M., Bucala, R., & Yamagishi, S. (2004) · Current Alzheimer Research · doi:10.2174/1567205043480582 · Cited by 127
Krautwald, M., & Münch, G. W. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.03.001 · Cited by 125
RAGE and amyloid beta interactions: Atomic force microscopy and molecular modeling
Chaney, M. O., Stine, W. B., Kokjohn, T. A., Kuo, Y., Esh, C. L., Rahman, A., Luehrs, D. C., Schmidt, A. M., Stern, D. M., Yan, S. D., et al. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2005.03.014 · Cited by 117
Advanced Glycation End Products and Diabetic Nephropathy
Thomas, M. C., Forbes, J. M., & Cooper, M. E. (2005) · American Journal of Therapeutics · doi:10.1097/01.mjt.0000178769.52610.69 · Cited by 117
The Blood–Brain Barrier in Alzheimer's Disease
Sharma, H. S., Castellani, R. J., Smith, M. A., & Sharma, A. (2012) · International review of neurobiology · doi:10.1016/b978-0-12-386986-9.00003-x · Cited by 111
Disruption of blood-brain barrier in Alzheimer disease pathogenesis
Kook, S. Y., Hong, H., Moon, M., & Mook‐Jung, I. (2013) · Tissue Barriers · doi:10.4161/tisb.23993 · Cited by 111
Choi, B.-R., Cho, W.-H., Kim, J., Lee, H. J., Chung, C., Jeon, W. K., & Han, J.-S. (2014) · Experimental & Molecular Medicine · doi:10.1038/emm.2013.147 · Cited by 111
Multitracer PET imaging of amyloid plaques and neurofibrillary tangles in Alzheimer's disease
Shin, J., Lee, S., Kim, S., Kim, Y.-B., & Cho, S. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.07.022 · Cited by 111
RAGE is a key cellular target for A -induced perturbation in Alzheimer s disease
Yan, S. S. (2011) · Frontiers in Bioscience-Scholar · doi:10.2741/265 · Cited by 111
Esposito, G., Scuderi, C., Lu, J., Savani, C., Filippis, D. D., Iuvone, T., Steardo, L., Jr., Sheen, V. L., & Steardo, L. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00159.x · Cited by 108
Chekir, C., Nakatsuka, M., Noguchi, S., Konishi, H., Kamada, Y., Sasaki, A., Hao, L., & Hiramatsu, Y. (2005) · Placenta · doi:10.1016/j.placenta.2005.02.016 · Cited by 107
Astroglial Activation of Extracellular-Regulated Kinase in Early Stages of Alzheimer Disease
Webster, B., Hansen, L. A., Adame, A., Crews, L. A., Torrance, M., Thal, L. J., & Masliah, E. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000199599.63204.6f · Cited by 103
Pinocembrin improves cognition and protects the neurovascular unit in Alzheimer related deficits
Liu, R., Li, J.-Z., Song, J., Zhou, D., Huang, C., Bai, X., Xie, T., Zhang, X., Li, Y., Wu, C., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.12.031 · Cited by 100
Perez, S. E., Raghanti, M. A., Hof, P. R., Kramer, L., Ikonomovic, M. D., Lacor, P. N., Erwin, J. M., Sherwood, C. C., & Mufson, E. J. (2013) · Journal of Comparative Neurology · doi:10.1002/cne.23428 · Cited by 95 · cited 2×
“As one of the hallmarks of AD, the NFTs eventually occupy the whole of the cytoplasm in certain classes of cell in the neocortex, hippocampus , brain stem, and diencephalon (Alafuzoff et al. 2008; Perez et al. 2013).”
BackgroundLv, C., Wang, L., Liu, X., Yan, S., Yan, S. S., Wang, Y., & Zhang, W. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.09.019 · Cited by 95
NF-κB-regulated, proinflammatory miRNAs in Alzheimer's disease
Lukiw, W. J. (2012) · Alzheimer s Research & Therapy · doi:10.1186/alzrt150 · Cited by 90
Wan, W., Chen, H., & Li, Y. (2013) · International Journal of Neuroscience · doi:10.3109/00207454.2013.825258 · Cited by 90
The Damage Signals Hypothesis of Alzheimer's Disease Pathogenesis
Fernández, J. A., Rojo, L. E., Kuljiš, R. O., & Maccioni, R. B. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-14307 · Cited by 89
Slowik, A., Merres, J., Elfgen, A., Jansen, S., Mohr, F., Wruck, C. J., Pufe, T., & Brandenburg, L. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-55 · Cited by 89
Bomba, M., Ciavardelli, D., Silvestri, E., Canzoniero, L. M. T., Lattanzio, R., Chiappini, P. B. O., Piantelli, M., Ilio, C. D., Consoli, A., & Sensi, S. L. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.139 · Cited by 89
Qureshi, H. Y., Li, T., MacDonald, R., Cho, C., Leclerc, N. M., & Paudel, H. K. (2013) · Biochemistry · doi:10.1021/bi400442d · Cited by 89
Zhang, M.-H., Feng, L., Zhu, M., Gu, J., Jiang, J., Cheng, X., Ding, S., Wu, C., & Jia, X. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.11.015 · Cited by 87
Investigations on oxidative stress and therapeutical implications in dementia
Durany, N., Münch, G. W., Michel, T. M., & Riederer, P. F. (1999) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/pl00014177 · Cited by 86
Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer's transgenic mice
Dobarro, M., Gereñu, G., & Ramírez, M. J. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000631 · Cited by 82
Rofina, J., Singh, K., Skoumalova-Vesela, A., van Ederen, A. M., van Asten, A. J., Wilhelm, J., & Gruys, E. (2004) · Amyloid · doi:10.1080/13506120412331285779 · Cited by 82
Abnormal processing of tau in the brain of aged TgCRND8 mice
Bellucci, A., Rosi, M. C., Grossi, C., Fiorentini, A., Luccarini, I., & Casamenti, F. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.06.008 · Cited by 80
Association between the RAGE G82S polymorphism and Alzheimer’s disease
Li, K., Dai, D., Zhao, B., Yao, L., Yao, S., Wang, B., & Yang, Z. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0334-6 · Cited by 79
Self-citationPerrone, L., & Grant, W. B. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-140720 · Cited by 78
Schmidt, M. L., Huang, R. T. C., Martin, J. A., Henley, J., Mawal-Dewan, M., Hurtig, H. I., Lee, V. M. Y., & Trojanowski, J. Q. (1996) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199605000-00006 · Cited by 78
Kuhla, A., Ludwig, S. C., Kuhla, B., Münch, G. W., & Vollmar, B. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.09.025 · Cited by 78
Methylglyoxal Induces Tau Hyperphosphorylation via Promoting AGEs Formation
Li, X., Xie, J., Jiang, X., Lv, B.-L., Cheng, X., Du, L., Zhang, J. Y., Wang, J., & Zhou, X. (2012) · NeuroMolecular Medicine · doi:10.1007/s12017-012-8191-0 · Cited by 76
Semba, R. D., Gebauer, S. K., Baer, D. J., Sun, K., Turner, R. L., Silber, H. A., Talegawkar, S. A., Ferrucci, L., & Novotny, J. A. (2014) · Journal of Nutrition · doi:10.3945/jn.113.189480 · Cited by 74
Iacono, D., Resnick, S. M., O’Brien, R., Zonderman, A. B., An, Y., Pletnikova, O., Rudow, G., Crain, B., & Troncoso, J. C. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000052 · Cited by 73
Caldeira, G. L., Ferreira, I. L., & Rego, A. C. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121444 · Cited by 73
Zhou, W.-W., Lü, S., Su, Y., Xue, D., Yu, X., Wang, S., Zhang, H., Xu, P., Xie, X.-X., & Liu, R. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.06.013 · Cited by 73
Qosa, H., LeVine, H., Keller, J. N., & Kaddoumi, A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.06.029 · Cited by 72
Xiao, Z., Cilz, N. I., Kurada, L., Hu, B., Yang, C., Wada, E., Combs, C. K., Porter, J. E., Lesage, F., & Lei, S. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0408-14.2014 · Cited by 71
Chen, S., An, F.-M., Yin, L., Liu, A.-R., Yin, D.-K., Yao, W.-B., & Gao, X.-D. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.10.038 · Cited by 68
Quade-Lyssy, P., Kanarek, A. M., Baiersdörfer, M., Postina, R., & Kojro, E. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m038968 · Cited by 67
Sato, N., Takeda, S., Uchio‐Yamada, K., Ueda, H., Fujisawa, T., Rakugi, H., & Morishita, R. (2011) · Current Aging Science · doi:10.2174/1874609811104020118 · Cited by 67
Wang, C.-Y., Xie, J.-W., Xu, Y., Wang, T., Cai, J.-H., Wang, X., Zhao, B.-L., An, L., & Wang, Z.-Y. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.5158 · Cited by 66 · cited 11×
“Glycation may be responsible via RAGE for an increase in oxidative stress and inflammation through the formation of reactive oxygen species and the induction of NF-jB (Vicente and Outeiro 2010; Wang et al. 2013).”
BackgroundInfluentialSelf-citationRapoport, S. I., Hatanpaa, K. J., Brady, D. R., & Chandrasekaran, K. (1996) · Neurodegeneration · doi:10.1006/neur.1996.0065 · Cited by 65
Tomoo, K., Yao, T., Minoura, K., Hiraoka, S., Sumida, M., Taniguchi, T., & Ishida, T. (2005) · The Journal of Biochemistry · doi:10.1093/jb/mvi142 · Cited by 65
Lue, L., Walker, D. G., Jacobson, S. A., & Sabbagh, M. N. (2009) · Future Neurology · doi:10.2217/14796708.4.2.167 · Cited by 64
The Role of the Blood-Brain Barrier in the Pathogenesis of Senile Plaques in Alzheimer’s Disease
Provias, J., & Jeynes, B. (2014) · International Journal of Alzheimer s Disease · doi:10.1155/2014/191863 · Cited by 60
Liang, F., Jia, J., Wang, S., Qin, W., & Liu, G. (2012) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2012.06.005 · Cited by 59
Wang, X., Yu, S., Hu, J.-P., Wang, C., Wang, Y., Liu, H.-X., & Liu, Y. (2013) · International Journal of Neuroscience · doi:10.3109/00207454.2013.866110 · Cited by 59
Self-citationJeong, J., Seo, J., Moon, M., Lee, Y.-J., Seol, J., & Park, S. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.09.037 · Cited by 57
Kosenko, E. A., Solomadin, I., Tikhonova, L. A., Reddy, V. P., Aliev, G., & Kaminsky, Y. G. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113126660130 · Cited by 55
Marksteiner, J., Imarhiagbe, D., Defrancesco, M., Deisenhammer, E., Kemmler, G., & Humpel, C. (2013) · Experimental Gerontology · doi:10.1016/j.exger.2013.12.001 · Cited by 55
Polydoro, M., de Calignon, A., Suárez‐Calvet, M., Sanchez, L., Kay, K. R., Nicholls, S. B., Roe, A. D., Pitstick, R., Carlson, G. A., Gómez‐Isla, T., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0881-13.2013 · Cited by 54
Isono, T., Yamashita, N., Obara, M., Araki, T., Nakamura, F., Kamiya, Y., Alkam, T., Nitta, A., Nabeshima, T., Mikoshiba, K., et al. (2013) · Neuroscience Research · doi:10.1016/j.neures.2013.08.005 · Cited by 52
Matrone, C., Djelloul, M., Taglialatela, G., & Perrone, L. (2015) · PubMed · doi:10.14670/hh-30.125 · Cited by 51
Tau hyperphosphorylation and increased BACE1 and RAGE levels in the cortex of PPARβ/δ-null mice
Barroso, E., del Valle, J., Porquet, D., Santos, A. M. V., Salvadó, L., Rodríguez‐Rodríguez, R., Gutiérrez, P., Anglada‐Huguet, M., Alberch, J., Camins, A., et al. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.03.006 · Cited by 51
Lee, Y. S., Kim, H. Y., Kim, Y.-H., Roh, E. J., Han, H., & Shin, K. J. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.10.022 · Cited by 48
Steele, J., Brautigam, H., Short, J. A., Sowa, A., Shi, M., Yadav, A., Weaver, C. M., Westaway, D. A., Fraser, P. E., George‐Hyslop, P. S., et al. (2014) · The Journal of Comparative Neurology · doi:10.1002/cne.23536 · Cited by 47
Les produits de glycation avancée : un risque pour la santé humaine
Wautier, M.-P., Tessier, F. J., & Wautier, J. (2014) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2014.05.002 · Cited by 45
Takeuchi, M., Sato, T., Takino, J.-I., Kobayashi, Y., Furuno, S., Kikuchi, S., & Yamagishi, S. (2007) · Medical Hypotheses · doi:10.1016/j.mehy.2006.12.017 · Cited by 44
Relationship of Advanced Glycation End Products With Cardiovascular Disease in Menopausal Women
Pertyńska−Marczewska, M., & Merhi, Z. O. (2014) · Reproductive Sciences · doi:10.1177/1933719114549845 · Cited by 39
Molecular Linkages Between Diabetes and Alzheimer's Disease: Current Scenario and Future Prospects
Dar, T. A., SHEIKH, I. A., Ganie, S. A., Ali, R., Singh, L. R., Gan, S. H., Kamal, M. A., & Zargar, M. A. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113126660135 · Cited by 38
Di, B., LI, H.-W., Li, W., Shen, X., SUN, Z.-J., & Wu, X. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.3113 · Cited by 35
Xu, L., Zang, P., Feng, B., & Qian, Q. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-102 · Cited by 33
Ramamurthy, B., & Larsson, L. (2013) · Biogerontology · doi:10.1007/s10522-013-9430-y · Cited by 32
Tancharoen, S., Tengrungsun, T., Suddhasthira, T., Kikuchi, K., Vechvongvan, N., Tokuda, M., & Maruyama, I. (2014) · Mediators of Inflammation · doi:10.1155/2014/754069 · Cited by 32
Yu, S., Wong, C. K., Szeto, C., Li, E. K., Cai, Z., & Tam, L. (2014) · Lupus · doi:10.1177/0961203314559631 · Cited by 31
Self-citationXie, C., Miyasaka, T., Yoshimura, S., Hatsuta, H., Yoshina, S., Kage-Nakadai, E., Mitani, S., Murayama, S., & Ihara, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089796 · Cited by 28 · cited 1×
“…in the N-terminal part, a proline-rich region, a region responsible for tau binding to microtubules containing four repeat domains R1, R2, R3, and R4 also called microtubule-binding domains (MBD) and a C-terminal region (Lee et al. 1988; de Silva et al. 2003; Tomoo et al. 2005; Xie et al. 2014).”
BackgroundMoriya, S., Yamazaki, M., Murakami, H., Maruyama, K., & Uchiyama, S. (2014) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2014.05.037 · Cited by 28
Fighting Alzheimer's Disease and Type 2 Diabetes: Pathological links and Treatment Strategies
Dai, Y., & Kamal, M. A. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113126660134 · Cited by 28
Heilmann, R. M., Otoni, C. C., Jergens, A. E., Grützner, N., Suchodolski, J. S., & Steiner, J. M. (2014) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2014.08.003 · Cited by 27
Monomeric Aβ1–42 and RAGE: key players in neuronal differentiation
Piras, S., Furfaro, A. L., Piccini, A., Passalacqua, M., Borghi, R., Carminati, E., Parodi, A., Colombo, L., Salmona, M., Pronzato, M. A., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.01.002 · Cited by 27 · cited 1×
“It seems that there is a novel physiological role for monomeric Ab and RAGE in neuronal differentiation (Piras et al. 2014).”
BackgroundSugihara, T., Munesue, S., Yamamoto, Y., Sakurai, S., Akhter, N., Kitamura, Y., Shiba, K., Watanabe, T., Yonekura, H., Hayashi, Y., et al. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110776 · Cited by 26
Amyloidosis, advanced glycation end products and Alzheimer disease
Smith, M. A., Monnier, V. M., Sayre, L. M., & Perry, G. L. (1995) · Neuroreport · doi:10.1097/00001756-199508000-00001 · Cited by 26
Bonetti, T. C., Borges, E., Braga, D. P. A. F., Iaconelli, A., Kleine, J. P. F. D. O., & da Silva, I. D. C. G. (2012) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2012.10.001 · Cited by 25
Perspectives on RAGE signaling and its role in cardiovascular disease
Cohen, M. M. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36181 · Cited by 24
Chen, X., Zhang, T., & Du, G. (2008) · Cell Biochemistry and Function · doi:10.1002/cbf.1502 · Cited by 24
Farmer, D., Ewart, M., Mair, K. M., & Kennedy, S. (2014) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2014.01.002 · Cited by 23
Humanin: a possible linkage between Alzheimer's disease and type 2 diabetes
Mahboobi, H., Golmirzaei, J., Gan, S., Jalalian, M., & Kamal, M. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527312666131223110147 · Cited by 21 · cited 1×
“Growing document shows that AD is fundamentally a metabolic disease with molecular and biochemical features that correspond with diabetes mellitus and other peripheral insulin resistance disorders (Dai and Kamal 2014; de la Monte and Tong 2014; Mahboobi et al. 2014; Wang et al. 2014).”
BackgroundMotoyoshi, S., Yamamoto, Y., Munesue, S., Igawa, H., Harashima, A., Saito, H., Han, D., Watanabe, T., Sato, H., & Yamamoto, H. (2014) · Biochemical Journal · doi:10.1042/bj20140084 · Cited by 20
Role of Citalopram in the Treatment of Agitation in Alzheimer’s Disease
Porsteinsson, A. P., Keltz, M., & Smith, J. S. (2014) · Neurodegenerative Disease Management · doi:10.2217/nmt.14.35 · Cited by 20
Franko, B., Brault, J., Jouvé, T., Beaumel, S., Benhamou, P., Zaoui, P., & Stasia, M. J. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.08.042 · Cited by 19
Neue Hypothese zur Ätiopathogenese des Alzheimer-Syndroms Advanced glycation endproducts (AGEs)
Thome, J., Kornhuber, J., Münch, G., Schinzel, R., Taneli, Y., Zielke, B., Rösler, M., & Riederer, P. (1996) · Der Nervenarzt · doi:10.1007/s001150050073 · Cited by 19
Folin (2009) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000199 · Cited by 18
[Neurobehavioral manifestation in early period of Alzheimer disease and vascular dementia].
Bidzan, M., & Bidzan, L. (2014) · PubMed · Cited by 17
Gasparotto, J., Senger, M. R., Kunzler, A., Degrossoli, A., De-Simone, S. G., Bortolin, R. C., Somensi, N., Girardi, C. S., de Souza, C. D. S. F., Calabrese, K. D. S., et al. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.06.204 · Cited by 16
Shemirani, F., & Yazdanparast, R. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.05.019 · Cited by 14
[Blood-brain barrier and Alzheimer's disease].
Kuwahara, H., Nishida, Y., & Yokota, T. (2013) · PubMed · Cited by 12
Tau-reactive neurofibrillary tangles in cerebellar cortex from patients with Alzheimer's disease
Tabaton, M., Cammarata, S., Manetto, V., Perry, G. L., & Mancardi, G. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90109-2 · Cited by 9
Mild Cognitive Impairment Due to Alzheimer Disease is Less Likely Under the Age of 65
Shin, S., Kim, J. H., Cho, J. H., Kim, G. S., Choi, S., & Lee, J. H. (2014) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000044 · Cited by 7
[AGEs and RAGE - advanced glycation end-products and their receptor in questions and answers].
Kalousová, M., & Zima, T. (2014) · PubMed · Cited by 4
Cited by
Inflammation in CNS neurodegenerative diseases
Stephenson, J., Nutma, E., van der Valk, P., & Amor, S. (2018) · Immunology · doi:10.1111/imm.12922 · Cited by 966
Perrone, A., Giovino, A., Benny, J., & Martinelli, F. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/3818196 · Cited by 459
Insulin and Insulin Resistance in Alzheimer’s Disease
Sędzikowska, A., & Szablewski, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189987 · Cited by 377
Sharma, P., Srivastava, P., Seth, A., Tripathi, P. N., Banerjee, A. G., & Shrivastava, S. K. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.12.006 · Cited by 331
Glycation Damage: A Possible Hub for Major Pathophysiological Disorders and Aging
Fournet, M., Bonté, F., & Desmoulière, A. (2018) · Aging and disease · doi:10.14336/ad.2017.1121 · Cited by 291
Metadata
- Authors
- Cai, Z., Liu, N., Wang, C., Qin, B., Zhou, Y., Xiao, M., Chang, L., Yan, L.-J., & Zhao, B.
- Venue
- Cellular and Molecular Neurobiology
- Published
- 2015-07-15
- Volume
- 36
- Issue
- 4
- Pages
- 483-495
- ISSN
- 0272-4340 (ISSN-L)
- 1573-6830
- OpenAlex
- W1903517070
- Cited by
- 285
- References
- 140
- FWCI
- 13.34
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.